Overview

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Status:
Completed

Trial end date:
2015-04-01

Target enrollment:

Participant gender:

Summary

POLARIS : A non-interventional study in patients with diabetic macular edema (DME) with central involvement to assess the effectiveness of existing anti-vascular endothelial growth factor (anti-VEGF) treatment regimens.

Details

Lead Sponsor:

Bayer

Collaborator:

Regeneron Pharmaceuticals

Treatments:

Bevacizumab
Endothelial Growth Factors
Ranibizumab